文献速递口腔修复与种植

原发性与继发性舍格伦综合征牙列患者牙种植的多中心前瞻性队列研究

Dental implants in dentate primary and secondary Sjögren's syndrome patients: A multicenter prospective cohort study.
PubMed 文献 · Clin Oral Implants Res · 2022-10-06

这项多中心前瞻性队列研究比较了原发性和继发性舍格伦综合征(pSS/sSS)牙列患者与非舍格伦综合征患者的牙种植临床性能与患者报告结局。pSS/sSS组17例植入37枚种植体,非SS组17例植入26枚,随访18个月。两组种植体存留率与边缘骨丧失无显著差异,但非SS组患者满意度和口腔健康相关生活质量在各时间点均显著更高。

要点

  • pSS/sSS组18个月种植体存留率100%,非SS组96.2%。
  • 18个月平均边缘骨丧失pSS/sSS组1.10±1.04 mm,非SS组1.04±0.75 mm,无显著差异(p=.87)。
  • pSS/sSS组种植修复后口腔健康相关生活质量较基线显著改善,但仍低于非SS组。

核心结论

  • 牙种植体可成功应用于pSS/sSS牙列患者,并对其口腔健康相关生活质量有积极影响。

研究设计与样本

  • 多中心前瞻性队列研究,pSS/sSS组17例患者植入37枚种植体,非SS组17例患者植入26枚种植体,用于替换缺失的(前)磨牙。

主要发现

  • 18个月时种植体存留率pSS/sSS组为100%,非SS组为96.2%。
  • 18个月时平均边缘骨丧失pSS/sSS组为1.10±1.04 mm,非SS组为1.04±0.75 mm,两组间无显著差异(p=.87)。
  • 所有临床指标在两组间均无显著差异(p>.05)。
  • pSS/sSS组在种植支持冠修复后各测量时点的口腔健康相关生活质量较基线均显著改善(p<.05)。
  • 非SS组患者满意度和口腔健康相关生活质量在所有测量时点均显著高于pSS/sSS组(p<.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To prospectively assess the clinical performance and patient-reported outcomes of dental implants in dentate patients with primary and secondary Sjögren's syndrome (pSS and sSS, respectively) compared to patients without SS. MATERIALS AND METHODS: Thirty-seven implants were placed in 17 patients with pSS/sSS and 26 implants in 17 non-SS patients to replace missing (pre)molars. Clinical performance, marginal bone-level changes, patient satisfaction, and oral health-related quality of life (OHRQoL) were assessed at 1 (T1), 6 (T6), 12 (T12), and 18 (T18) months after placement of the superstructure. Marginal bone-level changes were measured on standardized dental radiographs. Clinical parameters included implant and crown survival, plaque, bleeding and gingival indices, and probing depth. Patient satisfaction and OHRQoL were assessed with validated questionnaires. RESULTS: Implant survival at T18 was 100% in the patients with pSS/sSS and 96.2% in the non-SS group. Mean marginal bone loss at T18 did not differ between patients with pSS/sSS and non-SS patients, 1.10 ± 1.04 and 1.04 ± 0.75 mm, respectively (p = .87). Clinical performance was good with no differences between the groups for all outcome measures (p > .05). OHRQoL in patients with pSS/sSS had improved significantly after placement of implant supported crowns at all measuring moments compared to baseline (p < .05). Nevertheless, patient satisfaction and OHRQoL remained significantly higher for patients without SS at all measuring moments (p < .05). CONCLUSION: Dental implants can be successfully applied in dentate patients with pSS/sSS and have a positive effect on OHRQoL.

来源:Clin Oral Implants Res,查看原文。版权归原作者所有。

引用

  1. Maarse F, Fennis WMM, Twisk JWR, et al. Dental implants in dentate primary and secondary Sjögren's syndrome patients: A multicenter prospective cohort study. Clin Oral Implants Res. 2022. PMID: 36136091. doi:10.1111/clr.13998

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。